CLULEVIBART
UNII E9J36DZS7Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Clulevibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E9J36DZS7Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3078314-06-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E9J36DZS7Q

CAS Registry Number

3078314-06-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CLULEVIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14070

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Clulevibart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clulevibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Clulevibart

Common Names & Synonyms

H-gamma1 heavy chain Homo sapiens (1-456) [VH (Homo sapiens IGHV3-49*04 (87.0%) -(IGHD) -IGHJ3*01 (93.8%), CDR-IMGT [8.10.17] (26-33.51-60.99-115)) (1-126) -Homo sapiens IGHG1*01v, G1m17,1>G1m3,1 CH1 R120, CH3 D12, L14, 9-G1v21 CH2 Y15.1, T16, E18 (CH1 R120 (223) (127-224), hinge 1-15 (225-239), CH2 M15.1>Y (261), S16>T (263), T18>E (265) (240-349), CH3 D12 (365), L14 (367) (350-454), CHS (455-456)) (127-456)], (229-214')-disulfide with L-kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV1-17*03 (94.7%) -IGKJ1*01 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (235-235'':238-238'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

Immunoglobulin G1 [261-tyrosine,263-threonine,265-glutamic acid], anti-(respiratory syncytial virus F protein) (human monoclonal RB0026 γ1-chain), disulfide with human monoclonal RB0026 κ-chain, dimer

clulevibart [INN]

immunoglobulin G1-kappa, anti-[human respiratory syncytial virus (RSV) fusion glycoprotein F], Homo sapiens monoclonal antibody (clulevibart)

External Clinical & Regulatory Resources

Previous UNIIE9IX0V2TD5

Next UNIIE9J6F7N54U